|
HY-130118-5mg
|
MedChemexpress LLC
|
MRGPRX1 agonist 1 [CAS 2377379-39-8]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-130118-50mg
|
MedChemexpress LLC
|
MRGPRX1 agonist 1 [CAS 2377379-39-8]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-130118-1mL
|
MedChemexpress LLC
|
MRGPRX1 agonist 1 [CAS 2377379-39-8] (10mM in DMSO)
|
|
Neuroscience-Neuromodulation
|
|
|
HY-145191-10mg
|
MedChemexpress LLC
|
MrgprX2 antagonist-1 [CAS 2642162-06-7]
|
|
COVID-19-immunoregulation
|
|
|
HY-145191-100mg
|
MedChemexpress LLC
|
MrgprX2 antagonist-1 [CAS 2642162-06-7]
|
|
COVID-19-immunoregulation
|
|
|
HY-145191-25mg
|
MedChemexpress LLC
|
MrgprX2 antagonist-1 [CAS 2642162-06-7]
|
|
COVID-19-immunoregulation
|
|
|
HY-145191-5mg
|
MedChemexpress LLC
|
MrgprX2 antagonist-1 [CAS 2642162-06-7]
|
|
COVID-19-immunoregulation
|
|
|
HY-145191-50mg
|
MedChemexpress LLC
|
MrgprX2 antagonist-1 [CAS 2642162-06-7]
|
|
COVID-19-immunoregulation
|
|
|
HY-146220-10mg
|
MedChemexpress LLC
|
MrgprX2 antagonist-8 [CAS 2768216-96-0]
|
|
COVID-19-immunoregulation
|
|
|
HY-146220-100mg
|
MedChemexpress LLC
|
MrgprX2 antagonist-8 [CAS 2768216-96-0]
|
|
COVID-19-immunoregulation
|
|
|
HY-146220-25mg
|
MedChemexpress LLC
|
MrgprX2 antagonist-8 [CAS 2768216-96-0]
|
|
COVID-19-immunoregulation
|
|
|
HY-146220-5mg
|
MedChemexpress LLC
|
MrgprX2 antagonist-8 [CAS 2768216-96-0]
|
|
COVID-19-immunoregulation
|
|
|
HY-146220-50mg
|
MedChemexpress LLC
|
MrgprX2 antagonist-8 [CAS 2768216-96-0]
|
|
COVID-19-immunoregulation
|
|
|
HY-145997-1mg
|
MedChemexpress LLC
|
MRGPRX4 modulator-1 [CAS 2492596-61-7]
|
|
COVID-19-immunoregulation
|
|
|
HY-145997-10mg
|
MedChemexpress LLC
|
MRGPRX4 modulator-1 [CAS 2492596-61-7]
|
|
COVID-19-immunoregulation
|
|
|
HY-145997-5mg
|
MedChemexpress LLC
|
MRGPRX4 modulator-1 [CAS 2492596-61-7]
|
|
COVID-19-immunoregulation
|
|
|
HY-147051-10mg
|
MedChemexpress LLC
|
MRGPRX4 modulator-2 [CAS 2492595-24-9]
|
|
COVID-19-immunoregulation
|
|
|
HY-147051-100mg
|
MedChemexpress LLC
|
MRGPRX4 modulator-2 [CAS 2492595-24-9]
|
|
COVID-19-immunoregulation
|
|
|
HY-147051-25mg
|
MedChemexpress LLC
|
MRGPRX4 modulator-2 [CAS 2492595-24-9]
|
|
COVID-19-immunoregulation
|
|
|
HY-147051-5mg
|
MedChemexpress LLC
|
MRGPRX4 modulator-2 [CAS 2492595-24-9]
|
|
COVID-19-immunoregulation
|
|
|
HY-147051-50mg
|
MedChemexpress LLC
|
MRGPRX4 modulator-2 [CAS 2492595-24-9]
|
|
COVID-19-immunoregulation
|
|
|
HY-139253-10mg
|
MedChemexpress LLC
|
MRIA9 [CAS 2750707-05-0]
|
|
Cancer-Kinase/protease
|
|
|
HY-139253-25mg
|
MedChemexpress LLC
|
MRIA9 [CAS 2750707-05-0]
|
|
Cancer-Kinase/protease
|
|
|
HY-139253-5mg
|
MedChemexpress LLC
|
MRIA9 [CAS 2750707-05-0]
|
|
Cancer-Kinase/protease
|
|
|
HY-139253-50mg
|
MedChemexpress LLC
|
MRIA9 [CAS 2750707-05-0]
|
|
Cancer-Kinase/protease
|
|
